John Joseph Hurley - 13 Mar 2026 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Reporting relationship: Principal Accounting Officer
Issuer ticker: AVNS
Reported as of: 13 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Mar 2026, 17:26:54 UTC
Prior SEC filing: 11 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ John S. Fischer, as attorney-in-fact for John Joseph Hurley

Key filing fact

John Joseph Hurley filed Form 4 for AVANOS MEDICAL, INC. (AVNS) on 17 Mar 2026.

Key facts

This page summarizes John Joseph Hurley's Form 4 filing for AVANOS MEDICAL, INC. (AVNS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Mar 2026, 17:26.

Change

Previous filing in this sequence was filed on 11 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001924834 Primary reporting owner

Hurley John Joseph

Relationship: Principal Accounting Officer
Address: 5405 WINDWARD PARKWAY, SUITE 100, ALPHARETTA
Signature: /s/ John S. Fischer, as attorney-in-fact for John Joseph Hurley
Signature date: 17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVNS transaction

Common Stock

Award

Transaction value
Shares: +2,211
Change %: +19%
Price: $0.000000^*
Shares after: 13,592
Date: 13 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 13, 2027, 1/3 on March 13, 2028 and 1/3 on March 13, 2029. Each TRSU is the economic equivalent of one share of Common Stock.